Howard Hughes Medical Institute’s Qualcomm QCOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Buy
14,838
+14,606
+6,296% +$2.13M 0.46% 28
2025
Q4
$39.7K Hold
232
0.02% 54
2025
Q3
$38.6K Sell
232
-7
-3% -$1.11K 0.02% 56
2025
Q2
$38.1K Buy
+239
New +$35.2K 0.02% 54
2022
Q4
Sell
-55,000
Closed -$6.21M 35
2022
Q3
$6.21M Buy
+55,000
New +$7.56M 1.77% 26
2015
Q3
Sell
-55,000
Closed -$3.44M 176
2015
Q2
$3.44M Hold
55,000
0.73% 36
2015
Q1
$3.81M Hold
55,000
0.52% 37
2014
Q4
$4.09M Sell
55,000
-80,000
-59% -$5.86M 1.09% 28
2014
Q3
$10.1M Hold
135,000
2.25% 5
2014
Q2
$10.7M Buy
135,000
+14,525
+12% +$1.15M 1.8% 5
2014
Q1
$9.5M Buy
120,475
+27,507
+30% +$2.07M 1.35% 7
2013
Q4
$6.9M Buy
92,968
+1,549
+2% +$109K 1.04% 16
2013
Q3
$6.15M Sell
91,419
-508
-0.6% -$33.3K 0.94% 17
2013
Q2
$5.62M Buy
+91,927
New +$5.86M 1.85% 25

Other funds holding QCOM

Howard Hughes Medical Institute's QCOM Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its Qualcomm (QCOM) stake by 6,296% in Q1 2026, buying an estimated $2.13M and bringing the position to 14,838 shares worth $1.91M. The position accounts for 0.46% of the portfolio, ranked #28.

Howard Hughes Medical Institute first reported a position in QCOM in Q2 2013 and has held it in 14 quarters since. The position peaked at $10.7M in Q2 2014. 2,714 funds tracked by Wall St. Rank hold QCOM as of Q1 2026.

  • Howard Hughes Medical Institute held 14,838 shares of Qualcomm worth $1.91M as of Q1 2026.
  • Howard Hughes Medical Institute bought 14,606 Qualcomm shares in Q1 2026, an estimated $2.13M.
  • Qualcomm made up 0.46% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #28 holding.
  • Howard Hughes Medical Institute first reported a position in Qualcomm in Q2 2013 and has held it in 14 quarters since.
  • Howard Hughes Medical Institute's Qualcomm position peaked at $10.7M in Q2 2014.
  • 2,714 funds tracked by Wall St. Rank held Qualcomm as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.